An emerging role for Wnt and GSK3 signaling pathways in schizophrenia

Singh KK. An emerging role for Wnt and GSK3 signaling pathways in schizophrenia. Clin Genet 2013: 83: 511-517. (C) John Wiley & Sons A/S. Published by Blackwell Publishing Ltd, 2013 Schizophrenia is a disabling illness with limited treatment options. The underlying pathophysiology remains unknown, partially due to its heterogeneous nature, and a lack of understanding of the biological functions of genetic risk factors. Several signaling pathways have been implicated, however, with the varying degrees of support. In this article, I will focus on the converging evidence supporting a prominent role for Wnt and glycogen synthase kinase 3 (GSK3) signaling in the biological bases of schizophrenia. This includes current pharmacological therapies that target GSK3, animal model and cell-based studies, and recent human genetic findings that implicate Wnt and GSK3 signaling.